Cargando…

New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate

(1) Background: In their 60-year history, dimethyl fumarate and other salts of fumaric acid have been used for the treatment of psoriasis and other immune-mediated diseases for their immune-modulating properties. Over the years, new mechanisms of action have been discovered for this evergreen drug t...

Descripción completa

Detalles Bibliográficos
Autores principales: Matteo, Paolinelli, Federico, Diotallevi, Emanuela, Martina, Giulia, Radi, Tommaso, Bianchelli, Alfredo, Giacchetti, Anna, Campanati, Annamaria, Offidani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788528/
https://www.ncbi.nlm.nih.gov/pubmed/36559226
http://dx.doi.org/10.3390/pharmaceutics14122732
_version_ 1784858775825416192
author Matteo, Paolinelli
Federico, Diotallevi
Emanuela, Martina
Giulia, Radi
Tommaso, Bianchelli
Alfredo, Giacchetti
Anna, Campanati
Annamaria, Offidani
author_facet Matteo, Paolinelli
Federico, Diotallevi
Emanuela, Martina
Giulia, Radi
Tommaso, Bianchelli
Alfredo, Giacchetti
Anna, Campanati
Annamaria, Offidani
author_sort Matteo, Paolinelli
collection PubMed
description (1) Background: In their 60-year history, dimethyl fumarate and other salts of fumaric acid have been used for the treatment of psoriasis and other immune-mediated diseases for their immune-modulating properties. Over the years, new mechanisms of action have been discovered for this evergreen drug that remains a first-line treatment for several different inflammatory diseases. Due to its pleiotropic effects, this molecule is still of great interest in varied conditions, not exclusively inflammatory diseases. (2) Methods: The PubMed database was searched using combinations of the following keywords: dimethyl fumarate, pharmacokinetics, pharmacodynamics, adverse effects, psoriasis, multiple sclerosis, and clinical indications. This article reviews and updates the pharmacokinetics, mechanisms of action, and clinical indications of dimethyl fumarate. (3) Conclusions: The pharmacology of dimethyl fumarate is complex, fascinating, and not fully known. Progressive insights into the molecule’s mechanisms of action will make it possible to maximize its clinical efficacy, reduce concerns about adverse effects, and find other possible areas of application.
format Online
Article
Text
id pubmed-9788528
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97885282022-12-24 New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate Matteo, Paolinelli Federico, Diotallevi Emanuela, Martina Giulia, Radi Tommaso, Bianchelli Alfredo, Giacchetti Anna, Campanati Annamaria, Offidani Pharmaceutics Review (1) Background: In their 60-year history, dimethyl fumarate and other salts of fumaric acid have been used for the treatment of psoriasis and other immune-mediated diseases for their immune-modulating properties. Over the years, new mechanisms of action have been discovered for this evergreen drug that remains a first-line treatment for several different inflammatory diseases. Due to its pleiotropic effects, this molecule is still of great interest in varied conditions, not exclusively inflammatory diseases. (2) Methods: The PubMed database was searched using combinations of the following keywords: dimethyl fumarate, pharmacokinetics, pharmacodynamics, adverse effects, psoriasis, multiple sclerosis, and clinical indications. This article reviews and updates the pharmacokinetics, mechanisms of action, and clinical indications of dimethyl fumarate. (3) Conclusions: The pharmacology of dimethyl fumarate is complex, fascinating, and not fully known. Progressive insights into the molecule’s mechanisms of action will make it possible to maximize its clinical efficacy, reduce concerns about adverse effects, and find other possible areas of application. MDPI 2022-12-06 /pmc/articles/PMC9788528/ /pubmed/36559226 http://dx.doi.org/10.3390/pharmaceutics14122732 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Matteo, Paolinelli
Federico, Diotallevi
Emanuela, Martina
Giulia, Radi
Tommaso, Bianchelli
Alfredo, Giacchetti
Anna, Campanati
Annamaria, Offidani
New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
title New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
title_full New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
title_fullStr New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
title_full_unstemmed New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
title_short New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
title_sort new and old horizons for an ancient drug: pharmacokinetics, pharmacodynamics, and clinical perspectives of dimethyl fumarate
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788528/
https://www.ncbi.nlm.nih.gov/pubmed/36559226
http://dx.doi.org/10.3390/pharmaceutics14122732
work_keys_str_mv AT matteopaolinelli newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate
AT federicodiotallevi newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate
AT emanuelamartina newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate
AT giuliaradi newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate
AT tommasobianchelli newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate
AT alfredogiacchetti newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate
AT annacampanati newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate
AT annamariaoffidani newandoldhorizonsforanancientdrugpharmacokineticspharmacodynamicsandclinicalperspectivesofdimethylfumarate